Meet our supporters: Faye Maguire
Faye was part of #TeamRetinaUK in 2019. This is what she had to say in the run up to the race:
Search results
Faye was part of #TeamRetinaUK in 2019. This is what she had to say in the run up to the race:
Fundraising for Retina UK means a lot to me - both my dad and my nephew have been affected by inherited sight-loss, and I've seen first-hand the incredible work this charity does.
James was part of #TeamRetinaUK in 2020 when he took part in the first ever Virtual London Marathon. He talks about his experience and his motivation.
The project aims to develop a cost effective method of examining the entire ABCA4 gene to look for variations that might cause disease.
Since the publication of this newsletter our founder and honorary president Lynda Cantor MBE has passed away. We are all deeply saddened by this news.
This page explains the different types of genetic tests: diagnostic testing, predictive testing, carrier testing and research testing
Prof Mariya Moosajee at Moorfields Eye Hospital has asked us to share the message below about the clinical trial she is running. This trial is for a treatment that targets a particular section of the USH2A gene.
Choroideremia is a rare genetic condition resulting in progressive sight loss in men.
The FDA has given Ocugen permission to start their phase 3 gene therapy clinical trial for retinitis pigmentosa (RP).
The latest research news from Retina UK.